✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Nitrazepam is an investigational drug.
There have been 4 clinical trials for Nitrazepam. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2015.
The most common disease conditions in clinical trials are Epilepsy, Sleep Initiation and Maintenance Disorders, and Somatoform Disorders. The leading clinical trial sponsors are Astellas Pharma Inc, Matthew's Friends, and Alder Hey Children's NHS Foundation Trust.
There is one US patent protecting this investigational drug and fifteen international patents.
Recent Clinical Trials for Nitrazepam
|Ketogenic Diet in Infants With Epilepsy (KIWE)||Alder Hey Children's NHS Foundation Trust||Phase 4|
|Ketogenic Diet in Infants With Epilepsy (KIWE)||Birmingham Children's Hospital NHS Foundation Trust||Phase 4|
|Ketogenic Diet in Infants With Epilepsy (KIWE)||Birmingham Women's and Children's NHS Foundation Trust||Phase 4|
Top disease conditions for Nitrazepam
Top clinical trial sponsors for Nitrazepam
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Nitrazepam||See Plans and Pricing||Heterocyclic compound||Takeda Pharmaceutical Company Limited (Osaka, JP)||See Plans and Pricing|
|Nitrazepam||See Plans and Pricing||Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof||The Regents of the University of California (Oakland, CA)||See Plans and Pricing|
|Nitrazepam||See Plans and Pricing||Tamper-resistant pharmaceutical compositions of opioids and other drugs||COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA)||See Plans and Pricing|
|Nitrazepam||See Plans and Pricing||Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Nitrazepam||Canada||CA2961033||2034-09-11||See Plans and Pricing|
|Nitrazepam||European Patent Office||EP3192791||2034-09-11||See Plans and Pricing|
|Nitrazepam||Japan||JPWO2016039408||2034-09-11||See Plans and Pricing|
|Nitrazepam||World Intellectual Property Organization (WIPO)||WO2016039408||2034-09-11||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|